[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100542645":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":33,"responsibleParty":48,"collaborators":19,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":19,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":19,"studyType":63,"phases":64,"briefSummary":67,"conditions":68,"keywords":70,"overallStatus":35,"whyStopped":19,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Chulalongkorn University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Drospirenone","EXPERIMENTAL","Participants received Drospirenone 4 mg tablet orally once daily for 21-28 days",[13],"Drug: Drospirenone",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","4 mg tablet once daily",[9],null,[21],{"name":22,"affiliation":5,"role":23},"Punyawee Utaipatanacheep","PRINCIPAL_INVESTIGATOR",[25,29],{"name":22,"role":26,"phone":27,"phoneExt":19,"email":28},"CONTACT","+668-7515-4003","punyawee@docchula.com",{"name":30,"role":26,"phone":31,"phoneExt":19,"email":32},"Somsook Santibenchakul","+669-2265-7273","dr.somsook@gmail.com",[34],{"facility":5,"status":35,"city":36,"state":19,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"RECRUITING","Bangkok","10330","Thailand","TH",{"type":41,"coordinates":42},"Point",[43,44],100.50144,13.75398,{"lat":44,"lon":43},[47],{"name":22,"role":26,"phone":19,"phoneExt":19,"email":19},{"type":49,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100542645","phase-1-pharmacokinetics-of-drospirenone-only-pills-a-pre--and-post-bariatric-surgery-study-100542645",false,"NCT06345560","Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery Study","Pharmacokinetics of Drospirenone Only Pills in Obese Thai Women: A Pre- and Post-Bariatric Surgery Study","Inclusion Criteria:\n\n* Thai women aged 18-45 years who are obese and had an appointment for Bariatric surgery at Chulalongkorn Hospital\n* Need contraception\n* Able to use non-hormonal contraception during the study\n* Giving consent\n\nExclusion Criteria:\n\n* Pregnancy or history of giving birth within 3 months\n* Breastfeeding within the 6 months\n* History of using DMPA within 12 months\n* History of using other types of hormonal birth control pills within 4 weeks\n* History of bilateral oophorectomy or hysterectomy\n* Suspected ovarian tumor or pathological ovarian cyst\n* Regular cigarette smoking\n* Contraindications to Drospirenone","FEMALE","18 Years","45 Years",{"count":61,"type":62},16,"ESTIMATED","INTERVENTIONAL",[65,66],"PHASE1","PHASE2","The purpose of this study is to investigate whether bariatric surgery affects Drospirenone only pills absorption",[69],"Contraception",[71,72,73,74,75,76],"Drospirenone only pills","Obesity","Bariatric surgery","Roux-en-Y gastric bypass","Pharmacokinetics","Absorption","2026-03-17",{"date":79,"type":80},"2026-03-19","ACTUAL",{"date":82,"type":80},"2024-04-18",{"date":84,"type":62},"2026-07",{"name":5,"class":6},1]